chr5-13721269-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001369.3(DNAH5):c.12034-24T>C variant causes a intron change. The variant allele was found at a frequency of 0.13 in 1,613,384 control chromosomes in the GnomAD database, including 15,659 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..
Frequency
 Genomes: 𝑓 0.11   (  1181   hom.,  cov: 33) 
 Exomes 𝑓:  0.13   (  14478   hom.  ) 
Consequence
 DNAH5
NM_001369.3 intron
NM_001369.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  5.20  
Publications
7 publications found 
Genes affected
 DNAH5  (HGNC:2950):  (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009] 
DNAH5 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
This position, referring to a specific DNA site, is a probable branch point but rather VUS (scored 5 / 10). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.76). 
BP6
Variant 5-13721269-A-G is Benign according to our data. Variant chr5-13721269-A-G is described in ClinVar as Benign. ClinVar VariationId is 257989.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.145  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| DNAH5 | ENST00000265104.5 | c.12034-24T>C | intron_variant | Intron 70 of 78 | 1 | NM_001369.3 | ENSP00000265104.4 | |||
| DNAH5 | ENST00000681290.1 | c.11989-24T>C | intron_variant | Intron 70 of 78 | ENSP00000505288.1 | 
Frequencies
GnomAD3 genomes  0.108  AC: 16404AN: 152158Hom.:  1181  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
16404
AN: 
152158
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.108  AC: 26860AN: 249706 AF XY:  0.106   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
26860
AN: 
249706
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.133  AC: 194086AN: 1461108Hom.:  14478  Cov.: 32 AF XY:  0.130  AC XY: 94712AN XY: 726912 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
194086
AN: 
1461108
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
94712
AN XY: 
726912
show subpopulations 
African (AFR) 
 AF: 
AC: 
945
AN: 
33468
American (AMR) 
 AF: 
AC: 
3202
AN: 
44716
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
3747
AN: 
26132
East Asian (EAS) 
 AF: 
AC: 
87
AN: 
39682
South Asian (SAS) 
 AF: 
AC: 
2346
AN: 
86204
European-Finnish (FIN) 
 AF: 
AC: 
10887
AN: 
53358
Middle Eastern (MID) 
 AF: 
AC: 
527
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
165261
AN: 
1111404
Other (OTH) 
 AF: 
AC: 
7084
AN: 
60376
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.473 
Heterozygous variant carriers
 0 
 7814 
 15628 
 23441 
 31255 
 39069 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 5702 
 11404 
 17106 
 22808 
 28510 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.108  AC: 16399AN: 152276Hom.:  1181  Cov.: 33 AF XY:  0.109  AC XY: 8098AN XY: 74426 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
16399
AN: 
152276
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
8098
AN XY: 
74426
show subpopulations 
African (AFR) 
 AF: 
AC: 
1387
AN: 
41576
American (AMR) 
 AF: 
AC: 
1557
AN: 
15294
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
507
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
21
AN: 
5188
South Asian (SAS) 
 AF: 
AC: 
139
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
2322
AN: 
10596
Middle Eastern (MID) 
 AF: 
AC: 
28
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
10041
AN: 
68006
Other (OTH) 
 AF: 
AC: 
240
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.498 
Heterozygous variant carriers
 0 
 740 
 1481 
 2221 
 2962 
 3702 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 170 
 340 
 510 
 680 
 850 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
88
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:4 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia 3    Benign:1 
Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 BranchPoint Hunter 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.